| a b c d e f g h i j k l m n o p q r s t u v w x y z |
Genes Related to Hypertension |
||||
omimID |
Symbol |
Alias |
||
| *106180 | ACE, DCP1 | DIPEPTIDYL CARBOXYPEPTIDASE 1;
DCP1 ANGIOTENSIN I CONVERTING ENZYME; ACE, ACE1 |
||
| ACNIE | ||||
| *102620 | ACTA2, ACTSA | ACTIN, ALPHA, SMOOTH MUSCLE, AORTIC; ACTSA | ||
| *102540 | ACTC | ACTIN, ALPHA, CARDIAC MUSCLE; ACTC | ||
| *102680 | ADD1 | ADDUCIN 1 | ||
| *102681 | ADD2 | ADDUCIN 2 | ||
| *601568 | ADD3 | ADDUCIN 3 | ||
| *104219 | ADRA1A | ALPHA-1A-ADRENERGIC RECEPTOR; ADRA1A | ||
| *104220 | ADRA1B | ALPHA-1B-ADRENERGIC RECEPTOR; ADRA1B | ||
| *104221 | ADRA1C | ALPHA-1C-ADRENERGIC RECEPTOR; ADRA1C | ||
| *104222 | ADRA1D | ALPHA-1D-ADRENERGIC RECEPTOR; ADRA1D | ||
| *104210 | ADRA2A | ALPHA-2A-ADRENERGIC RECEPTOR; ADRA2A | ||
| *104260 | ADRA2B | ALPHA-2B-ADRENERGIC RECEPTOR; ADRA2B | ||
| *104250 | ADRA2C | ALPHA-2C-ADRENERGIC RECEPTOR ADRA2C | ||
| *109690 | ADRB2 | BETA-2-ADRENERGIC RECEPTOR; ADRB2 | ||
| *109691 | ADRB3 | BETA-3-ADRENERGIC RECEPTOR; ADRB3 | ||
| *106150 | AGT | ANGIOTENSIN I ANGIOTENSINOGEN, ANGIOTENSIN II |
||
| *106165 | AGTR1 | ANGIOTENSIN RECEPTOR 1; AGTR1 | ||
| *300034 | AGTR2 | ANGIOTENSIN II RECEPTOR, TYPE
2; AGTR2 |
||
| *180960 | AHCY | S-ADENOSYLHOMOCYSTEINE HYDROLASE; AHCY | ||
| 300800 | AHO | ALBRIGHT HEREDITARY OSTEODYSTROPHY | ||
| #103580 | AHO | ALBRIGHT HEREDITARY OSTEODYSTROPHY | ||
| 203330 | AHO | ALBRIGHT HEREDITARY OSTEODYSTROPHY | ||
| 103581 | AHO2 | ALBRIGHT HEREDITARY OSTEODYSTROPHY-2 | ||
| *176000 | AIP | PORPHYRIA, ACUTE INTERMITTENT | ||
| 218030 | AME | APPARENT MINERALOCORTICOID
EXCESS; AME; AME1 11-@BETA-HYDROXYSTEROID DEHYDROGENASE, TYPE II, INCLUDED; HSD11B2, INCLUDED 11-@BETA-HSD, INCLUDED HSD11, KIDNEY AND PLACENTAL TYPE, INCLUDED; HSD11K, INCLUDED HSD11, TYPE II, INCLUDED |
||
| 207765 | AME2 | APPARENT MINERALOCORTICOID EXCESS, TYPE 2 | ||
| *108780 | ANF, ANP, NPPA | ATRIAL NATRIURETIC FACTOR; ANF ATRIAL NATRIURETIC POLYPEPTIDES; ANP NATRIURETIC PEPTIDE PRECURSOR A; NPPA |
||
| *108962 | NPR3, ANPRC | NATRIURETIC PEPTIDE RECEPTOR C;
NPR3 ATRIAL NATRIURETIC PEPTIDE CLEARANCE RECEPTOR; ANPRC ATRIONATRIURETIC PEPTIDE RECEPTOR, TYPE C |
||
| *600296 | ANFC, NPPC, CNP | ATRIAL NATRIURETIC PEPTIDE,
TYPE C NATRIURETIC PEPTIDE PRECURSOR C; NPPC NATRIURETIC PEPTIDE, TYPE C; CNP |
||
| *108961 | ANPRB, NPR2, ANF-Rb | ATRIAL NATRIURETIC PEPTIDE
RECEPTOR, TYPE B; ANPRB NATRIURETIC PEPTIDE RECEPTOR B/GUANYLATE CYCLASE B; NPR2 |
||
| *105850 | ANG | ANGIOGENIN, RIBONUCLEASE A FAMILY, 5; ANG | ||
| *107680 | APOA1 | APOLIPOPROTEIN A-I OF HIGH DENSITY LIPOPROTEIN | ||
| *106700 | APVR | ANOMALOUS PULMONARY VENOUS RETURN | ||
| *106165 | AGTR1, AGTR1A, ATR1 | ANGIOTENSIN I RECEPTOR,
VASCULAR TYPE 1 ANGIOTENSIN RECEPTOR 1; AGTR1 |
||
| *300058 | AGTR2 | ANGIOTENSIN II RECEPTOR, TYPE 2; AGTR2 | ||
| #105830 | AS | ANGELMAN SYNDROME; AS ANGELMAN SYNDROME CHROMOSOME REGION; ANCR HAPPY PUPPET SYNDROME |
||
| *182310 | ATP1A1 | SODIUM-POTASSIUM-ATPase,
ALPHA-1 POLYPEPTIDE Na,K-ATPase, ALPHA-A CATALYTIC POLYPEPTIDE Na,K-ATPase, ALPHA-1 POLYPEPTIDE; ATP1A1 |
||
| *182340 | ATP1A2 | ATPase, Na+/K+ TRANSPORTING, ALPHA-2 POLYPEPTIDE; ATP1A2 | ||
| *182350 | ATP1A3 | ATPase, Na+/K+ TRANSPORTING, ALPHA-3 POLYPEPTIDE; ATP1A3 | ||
| *182330 | ATP1B1 | ATPase, Na+/K+ TRANSPORTING, BETA-1 POLYPEPTIDE; ATP1B1 | ||
| *182331 | ATP1B2 | ATPase, Na+/K+ TRANSPORTING, BETA-2 POLYPEPTIDE; ATP1B2 | ||
| *601867 | ATP1B3 | ATPase, Na+/K+ TRANSPORTING, BETA-3 POLYPEPTIDE; ATP1B3 | ||
| *108740 | ATP2A2 | ATPase, Ca(2+)-TRANSPORTING, SLOW-TWITCH | ||
| #301040 | ATRX | ATR, NONDELETION TYPE; ATR2 X-LINKED ALPHA-THALASSEMIA/MENTAL RETARDATION ATR-X SYNDROME; ATRX |
||
| #301050 | ATS | ALPORT SYNDROME, X-LINKED | ||
| *192340 | AVP | ARGININE VASOPRESSIN; AVP | ||
| *600821 | AVPR1A | ARGININE VASOPRESSIN RECEPTOR 1A; AVPR1A | ||
| *600254 | AVPR1B | ARGININE VASOPRESSIN RECEPTOR
1B; ANTIDIURETIC HORMONE, RECEPTOR FOR, V1B VASOPRESSIN V1B RECEPTOR PITUITARY VASOPRESSIN RECEPTOR 3; AVPR3 |
||
| *304800 | AVPR2 | DIABETES INSIPIDUS, NEPHROGENIC NEPHROGENIC DIABETES INSIPIDUS, TYPE I; NDI DIABETES INSIPIDUS, RENAL; DIR ARGININE VASOPRESSIN RECEPTOR 2, INCLUDED; AVPR2, INCLUDED ANTIDIURETIC HORMONE RECEPTOR, INCLUDED; ADHR, INCLUDED VASOPRESSIN V2 RECEPTOR, INCLUDED; V2R, INCLUDED |
||
| *600309 | AVSD | ATRIOVENTRICULAR SEPTAL DEFECT | ||
| *602682 | BAI1 | BRAIN-SPECIFIC ANGIOGENESIS INHIBITOR 1; BAI1 | ||
| *209900 | BBS2 | BARDET-BIEDL SYNDROME, TYPE 2 | ||
| *600151 | BBS3 | BARDET-BIEDL SYNDROME, TYPE 3 | ||
| *600374 | BBS4 | BARDET-BIEDL SYNDROME, TYPE 4 | ||
| *600337 | BKR1, BDKRB1 | BRADYKININ RECEPTOR B1; BDKRB1 | ||
| *113503 | BKR2, BDKRB2 | BRADYKININ RECEPTOR B2; BDKRB2 BRADYKININ RECEPTOR 2; BKR2 |
||
| *300107 | BRS3 | BOMBESIN-LIKE RECEPTOR 3 | ||
| #130650 | BWS | BECKWITH-WIEDEMANN SYNDROME | ||
| *120810 | C4A | COMPLEMENT COMPONENT 4A | ||
| CACM2 | ? | |||
| CACNIS | ? | |||
| *601763 | CASP8 | APOPTOSIS-RELATED CYSTEINE PROTEASE; CASP8 | ||
| *114090 | CAST | CALPASTATIN | ||
| *123833 | CCND2 | Cyclin D2 | ||
| *116953 | CDK2 | CELL DIVISION KINASE 2 p33(CDK2) | ||
| *602421 | CFTR | CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | ||
| *114130 | CGRP, CALCA, CALC1 | CALCITONIN/CALCITONIN-RELATED POLYPEPTIDE, ALPHA; CALCA | ||
| *114190 | CGRPR | CALCITONIN GENE-RELATED PEPTIDE RECEPTOR; CGRPR | ||
| *100730 | CHRNG, ACHRG | ACETYLCHOLINE RECEPTOR, MUSCLE,
GAMMA SUBUNIT; ACHRG CHOLINERGIC RECEPTOR, NICOTINIC, GAMMA POLYPEPTIDE; CHRNG |
||
| *100725 | CHRNE | CHOLINERGIC RECEPTOR,
NICOTINIC, EPSILON POLYPEPTIDE; CHRNE ACETYLCHOLINE RECEPTOR, MUSCLE, EPSILON SUBUNIT; ACHRE |
||
| *216400 | CKN1 | COCKAYNE SYNDROME, TYPE I | ||
| CLCNKB | ||||
| *601170 | CMD1,CMD2, CMD3,CMD4 |
MUSCULAR DYSTROPHY, CONGENITAL, WITH SEVERE CENTRAL NERVOUS SYSTEM ATROPHY AND ABSENCE OF LARGE MYELINATED FIBERS | ||
| *601494 | CMD1D | CARDIOMYOPATHY, DILATED, 1D; CMD1D | ||
| *601154 | CMD1E | CARDIOMYOPATHY, DILATED, 1E; CMD1E | ||
| *600858 | CMH | CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, WITH WOLFF-PARKINSON-WHITE SYNDROME | ||
| #192600 | CMH1 | CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1 | ||
| #115195 | CMH2 | CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 2; CMH2 | ||
| #115196 | CMH3 | CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 3; CMH3 | ||
| #115197 | CMH4 | CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4; CMH4 | ||
| 219250 | CMTC | CUTIS MARMORATA TELANGIECTATICA CONGENITA | ||
| *116790 | COMT | CATECHOL-O-METHYLTRANSFERASE | ||
| *303630 | COL4A5 | COLLAGEN, TYPE IV, ALPHA-5; COL4A5 | ||
| *600584 | CSX | CARDIAC-SPECIFIC HOMEO BOX; CSX | ||
| *121009 | CTGF | CONNECTIVE TISSUE GROWTH FACTOR; CTGF | ||
| *600435 | CTF1 | CARDIOTROPHIN 1; CTF1 |
||
| *202010 | CYP11B1 | ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 11-@BETA-HYDROXYLASE DEFICIENCY | ||
| *124080 | CYP11B2 | CYTOCHROME P450, SUBFAMILY XIB, POLYPEPTIDE 2; CYP11B2 | ||
| *202110 | CYP17-ALPHA | DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY | ||
| #124200 | DAR | DARIER-WHITE DISEASE; DAR KERATOSIS FOLLICULARIS DARIER DISEASE; DD |
||
| *223360 | DBH | DOPAMINE BETA-HYDROXYLASE, PLASMA | ||
| *106180 | DCP1 | DIPEPTIDYL CARBOXYPEPTIDASE-1 | ||
| *125660 | DES | DESMIN | ||
| *126449 | DRD1 | DOPAMINE RECEPTOR D1 | ||
| *126450 | DRD2 | DOPAMINE RECEPTOR D2; DRD2 | ||
| *126451 | DRD3 | DOPAMINE RECEPTOR D3; DRD3 | ||
| *126452 | DRD4 | DOPAMINE RECEPTOR D4; DRD4 | ||
| *126453 | DRD5 | DOPAMINE RECEPTOR D5; DRD5 | ||
| 126448 | DRD1B | DOPAMINE RECEPTOR D1B | ||
| *223900 | DYS | DYSAUTONOMIA, FAMILIAL | ||
| *127700 | DYX1 | DYSLEXIA, SPECIFIC, 1 | ||
| *600423 | ECE1 | ENDOTHELIN CONVERTING ENZYME 1; ECE1 | ||
| *130160 | ELN | ELASTIN | ||
| *133171 | EPOR | ERYTHROPOIETIN RECEPTOR | ||
| *133430 | ESR | ESTROGEN RECEPTOR 1; ESR1 | ||
| *601663 | ESR2 | ESTROGEN RECEPTOR 2; ESR2 | ||
| *131240 | EDN1,ET1 | ENDOTHELIN 1; EDN1 | ||
| *131241 | EDN2 | ENDOTHELIN 2; EDN2 | ||
| *131242 | EDN3 | ENDOTHELIN 3 | ||
| *131243 | EDNRA | ENDOTHELIN RECEPTOR, TYPE A; EDNRA | ||
| *131244 | EDNRB,ETRB, ETRB | ENDOTHELIN RECEPTOR, TYPE B; EDNRB | ||
| *134820 | FGA | FIBRINOGEN, A ALPHA POLYPEPTIDE | ||
| *305400 | FGDY | FACIOGENITAL DYSPLASIA | ||
| *131220 | FGF1 | FIBROBLAST GROWTH FACTOR 1; FGF1 | ||
| *164950 | FGF3 | FIBROBLAST GROWTH FACTOR 3 | ||
| *164980 | FGF4 | FIBROBLAST GROWTH FACTOR 4 | ||
| *134921 | FGF6 | FIBROBLAST GROWTH FACTOR 6 | ||
| *134795 | FLRN | FIBRILLARIN | ||
| *136132 | FMO3 | FLAVIN-CONTAINING MONOOXYGENASE 3 | ||
| *164810 | FOS | V-FOS FBJ MURINE OSTEOSARCOMA VIRAL ONCOGENE HOMOLOG; FOS | ||
| *229300 | FRDA1 | FRIEDREICH ATAXIA 1 | ||
| *600576 | GATA4 | GATA-BINDING PROTEIN 4; GATA4 | ||
| *138033 | GCGR | GLUCAGON RECEPTOR | ||
| *230800 | GD I | GAUCHER DISEASE, TYPE I | ||
| #301500 | GLA | ANGIOKERATOMA, DIFFUSE | ||
| #137750 | GLC1A | GLAUCOMA 1, OPEN ANGLE | ||
| *137760 | GLC1B | GLAUCOMA 1, OPEN ANGLE, B | ||
| *139130 | GNB3 | GUANINE NUCLEOTIDE-BINDING PROTEIN, BETA POLYPEPTIDE-3 | ||
| *600240 | GPR2 | G PROTEIN-COUPLED RECEPTOR 2; GPR2 | ||
| *138040 | GR | GLUCOCORTICOID RECEPTOR | ||
| *232200 | GSD-I | GLYCOGEN STORAGE DISEASE I | ||
| *600364 | GUC1A1 | GUANYLATE CYCLASE ACTIVATOR 1A; GUCA1A | ||
| *602275 | GUC1A2 | GUANYLATE CYCLASE ACTIVATOR 1B; GUCA1B | ||
| GUC1A3 | ||||
| GUC1B3 | ||||
| *139392 | GUCA2A | GUANYLATE CYCLASE ACTIVATOR 2A; GUCA2A | ||
| *601271 | GUCA2B | GUANYLATE CYCLASE ACTIVATOR 2B; GUCA2B | ||
| GUCA2C | ||||
| *601330 | GUCY2C | GUANYLATE CYCLASE 2C; GUCY2C | ||
| *138570 | GYS1 | GLYCOGEN SYNTHASE 1 | ||
| *143450 | HADHB | HYDROXYACYL-CoA DEHYDROGENASE/3-KETOACYL-CoA THIOLASE/ENOYL-CoA HYDRATASE, BETA SUBUNIT | ||
| *141900 | HBB | HEMOGLOBIN--BETA LOCUS | ||
| *300043 | HDGF | HEPATOMA-DERIVED GROWTH FACTOR; HDGF | ||
| *142695 | HDLBP | HIGH DENSITY LIPOPROTEIN-BINDING PROTEIN; HDLBP | ||
| *142409 | HGF | HEPATOCYTE GROWTH FACTOR; HGF | ||
| #187300 | HHT | TELANGIECTASIA, HEREDITARY HEMORRHAGIC, OF RENDU, OSLER AND WEBER | ||
| #176000 | HMBS | PORPHYRIA, ACUTE INTERMITTENT | ||
| *141250 | HMOX1 | HEME OXYGENASE 1; HMOX1 | ||
| #141251 | HMOX2 | HEME OXYGENASE 2; HMOX2 | ||
| #142900 | HOS | HOLT-ORAM SYNDROME | ||
| *600167 | HRH1 | HISTAMINE RECEPTOR H1; HRH1 | ||
| *142703 | HRH2 | HISTAMINE RECEPTOR, H2 SUBCLASS; HRH2 | ||
| *600713 | HSD11B1 | 11-@BETA-HYDROXYSTEROID DEHYDROGENASE, TYPE I | ||
| 218030 | HSD11B2 | CORTISOL 11-BETA-KETOREDUCTASE
DEFICIENCY 11-@BETA-HYDROXYSTEROID DEHYDROGENASE, TYPE II, INCLUDED; HSD11B2 |
||
| HSD17B | ||||
| *109684 | HSD17B1 | 17-@BETA-HYDROXYSTEROID DEHYDROGENASE I; HSD17B1 | ||
| #109685 | HSD17B2 | 17-@BETA-HYDROXYSTEROID DEHYDROGENASE II; HSD17B2 | ||
| *264300 | HSD17B3 | PSEUDOHERMAPHRODITISM,
MALE, WITH GYNECOMASTIA; 17-@KETOSTEROID REDUCTASE DEFICIENCY OF TESTIS 17-@KSR DEFICIENCY NEUTRAL 17-BETA-HYDROXYSTEROID OXIDOREDUCTASE DEFICIENCY 17-@BETA HYDROXYSTEROID DEHYDROGENASE 3, INCLUDED; HSD17B3, INCLUDED 17-@BETA-HSD III, INCLUDED ESTRADIOL 17-BETA-DEHYDROGENASE, INCLUDED; EDH17B3, INCLUDED TESTICULAR 17-@BETA-HYDROXYSTEROID DEHYDROGENASE III POLYCYSTIC OVARIAN DISEASE DUE TO 17-KETOSTEROID REDUCTASE DEFICIENCY, INCLUDED |
||
| *601860 | HSD17B4 | 17-@BETA-HYDROXYSTEROID DEHYDROGENASE IV; HSD17B4 | ||
| #109715 | HSD3B1 | 3-@BETA-HYDROXYSTEROID DEHYDROGENASE/DELTA-ISOMERASE, TYPE I | ||
| #201810 | HSD3B2 | ADRENAL HYPERPLASIA II | ||
| *312861 | HTR2C | 5-@HYDROXYTRYPTAMINE RECEPTOR 2C; HTR2C | ||
| #142900 | HOS | HOLT-ORAM SYNDROME | ||
| *307800 | HYP | HYPOPHOSPHATEMIA, VITAMIN D-RESISTANT RICKETS | ||
| *146630 | ICAM2 | INTERCELLULAR ADHESION MOLECULE 2; ICAM2 | ||
| *146631 | ICAM3 | INTERCELLULAR ADHESION MOLECULE 3; ICAM3 | ||
| *222100 | IDDM | DIABETES MELLITUS, JUVENILE-ONSET INSULIN-DEPENDENT | ||
| *147570 | IFNG | INTERFERON, GAMMA; IFNG | ||
| *147573 | IFNR | INTERFERON PRODUCTION REGULATOR; IFNR | ||
| *107450 | IFNAR1 | INTERFERON, ALPHA, BETA, AND OMEGA, RECEPTOR 1; IFNAR1 | ||
| *602376 | IFNAR2 | INTERFERON, ALPHA, BETA, AND OMEGA, RECEPTOR 2; IFNAR2 | ||
| 147050 | IGER | IgE RESPONSIVENESS, ATOPIC; IGER | ||
| 147440 | IGF1 | INSULIN-LIKE GROWTH FACTOR I; IGF1 | ||
| 147370 | IGF1R | INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR; IGF1R | ||
| 147470 | IGF2 | INSULIN-LIKE GROWTH FACTOR II; IGF2 | ||
| *146790 | IGFR2 | Fc FRAGMENT OF IgG, LOW
AFFINITY IIa, RECEPTOR FOR; FCGR2A, FCG2 IMMUNOGLOBULIN G Fc RECEPTOR II; FcGR; IGFR2, CDw32, CD32 |
||
| 146732 | IGFBP3 | INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 3; IGFBP3 | ||
| *147720 | IL1B | INTERLEUKIN 1-BETA; IL1B | ||
| *147810 | IL1R1 | INTERLEUKIN 1 RECEPTOR, TYPE I; IL1R1 | ||
| *146928 | IL8RB | INTERLEUKIN 8 RECEPTOR, BETA; IL8RB | ||
| *124092 | IL10 | INTERLEUKIN 10; IL10 | ||
| *147660 | IFNA1 | INTERFERON, ALPHA-1; IFNA1 | ||
| *147640 | IFNB1 | INTERFERON, BETA-1; IFNB1 | ||
| *107450 | IFNAR1 | INTERFERON, ALPHA, BETA, AND OMEGA, RECEPTOR 1; IFNAR1 | ||
| *147569 | IFNGR2 | INTERFERON, GAMMA, RECEPTOR 2; IFNGR2 | ||
| 600797 | IRS2 | INSULIN RECEPTOR SUBSTRATE 2 | ||
| *173470 | ITGB3 | INTEGRIN, BETA-3 | ||
| *176266 | KCNA4 | POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, MEMBER 4; KCNA4 | ||
| *176257 | KCNA6 | POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, MEMBER 6; KCNA6 | ||
| *603305 | KCNH1 | POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY H, MEMBER 1; KCNH1 | ||
| *152427 | KCNH2, LQT2 | LONG QT SYNDROME 2; LQT2 | ||
| *600359 | KCNJ1 | POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 1; KCNJ1 | ||
| *600681 | KCNJ2 | POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 2; KCNJ2 | ||
| *601534 | KCNJ3 | POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 3; KCNJ3 | ||
| *600504 | KCNJ4 | POTASSIUM
CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 4; KCNJ4 |
||
| *600734 | KCNJ5 | POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 5; KCNJ5 ... | ||
| *602106 | KCNJ15 | POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 15; KCNJ15 | ||
| *601745 | KCNK1 | POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 1; KCNK1 | ||
| *603219 | KCNK2 | POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 2; KCNK2 | ||
| *603220 | KCNK3 | POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 3; KCNK3 | ||
| *603888 | KCNS3 | POTASSIUM CHANNEL, VOLTAGE-GATED, DELAYED-RECTIFIER, SUBFAMILY S, MEMBER 3; KCNS3 | ||
| *147910 | KLK1 | KALLIKREIN 1; KLK1 | ||
| *147960 | KLK2 | KALLIKREIN 2, PROSTATE-SPECIFIC; KLK2 | ||
| *176820 | KLK3 | KALLIKREIN 3;
KLK3 |
||
| *228960 | KNG | FLAUJEAC FACTOR DEFICIENCY HIGH MOLECULAR WEIGHT KININOGEN DEFICIENCY HMWK DEFICIENCY KININOGEN DEFICIENCY, TOTAL, FITZGERALD FACTOR DEFICIENCY, WILLIAMS FACTOR DEFICIENCY, KININOGEN, KNG |
||
| *164160 | LEP | LEPTIN; LEP | ||
| *601007 | LEPR | LEPTIN RECEPTOR; LEPR | ||
| LMD1B | ? LMDIB | |||
| LNGFR | ? | |||
| *238600 | LPL | HYPERLIPOPROTEINEMIA, TYPE ILIPOPROTEIN LIPASE DEFICIENCYLPL DEFICIENCY | ||
| *600919 | LQT4 | LONG QT SYNDROME 4; LQT4 | ||
| *602634 | MDG1 | MICROVASCULAR ENDOTHELIAL DIFFERENTIATION GENE 1; MDG1 | ||
| *600983 | MLR | MINERALOCORTICOID RECEPTOR; MLR | ||
| *178990 | MMP7 | MATRIX METALLOPROTEINASE 7; MMP7 | ||
| *120355 | MMP8 | MATRIX METALLOPROTEINASE 8; MMP8 | ||
| *236250 | MTHFR | 5,10-@METHYLENETETRAHYDROFOLATE REDUCTASE | ||
| *160760 | MYH7 | MYOSIN, HEAVY CHAIN 7, CARDIAC MUSCLE, BETA; MYH7 | ||
| *256700 | NB | NEUROBLASTOMA | ||
| *162200 | NF1 | NEUROFIBROMATOSIS, TYPE I | ||
| *164012 | NFKB2 | NUCLEAR FACTOR KAPPA-B, SUBUNIT 2; NFKB2 | ||
| *162010 | NGFR | NERVE GROWTH FACTOR RECEPTOR; NGFR | ||
| *163731 | NOS1 | NITRIC OXIDE SYNTHASE 1; NOS1 | ||
| *163730 | NOS2A | NITRIC OXIDE SYNTHASE 2A; NOS2A | ||
| *600719 | NOS2B | NITRIC OXIDE SYNTHASE, MACROPHAGE, TYPE 2B; NOS2B | ||
| *600720 | NOS2C | NITRIC OXIDE SYNTHASE, MACROPHAGE, TYPE 2C; NOS2C | ||
| *163729 | NOS3 | NITRIC OXIDE SYNTHASE 3 | ||
| *256100 | NPHP1 | NEPHRONOPHTHISIS, FAMILIAL JUVENILE 1 | ||
| *108780 | NPPA | NATRIURETIC PEPTIDE PRECURSOR A | ||
| *600295 | NPPB | NATRIURETIC PEPTIDE PRECURSOR B; NPPB | ||
| *600296 | NPPC | NATRIURETIC PEPTIDE PRECURSOR C; NPPC | ||
| *108960 | NPR1 | NATRIURETIC PEPTIDE RECEPTOR A/GUANYLATE CYCLASE A | ||
| *108961 | NPR2 | NATRIURETIC PEPTIDE RECEPTOR B/GUANYLATE CYCLASE B; NPR2 | ||
| *108962 | NPR3 | NATRIURETIC PEPTIDE RECEPTOR C | ||
| *161200 | NPS1 | NAIL-PATELLA SYNDROME | ||
| *162640 | NPY | NEUROPEPTIDE Y; NPY | ||
| *162641 | NPY1R | NEUROPEPTIDE Y RECEPTOR Y1; NPY1R | ||
| *601770 | NPY6R | NEUROPEPTIDE Y RECEPTOR Y6 | ||
| *162650 | NTS | NEUROTENSIN ; NTS | ||
| *167055 | OXTR | OXYTOCIN RECEPTOR; OXTR | ||
| *173360 | PAI1 | PLASMINOGEN ACTIVATOR INHIBITOR, TYPE 1; PAI1 | ||
| *167409 | PAX2 | PAIRED BOX HOMEOTIC GENE 2 | ||
| *176740 | PCNA | PROLIFERATING CELL NUCLEAR ANTIGEN; PCNA | ||
| 173430 | PDGFA | PLATELET-DERIVED GROWTH FACTOR, ALPHA POLYPEPTIDE; PDGFA | ||
| 190040 | PDGFB | PLATELET-DERIVED GROWTH FACTOR, BETA POLYPEPTIDE; PDGFB | ||
| 173410 | PDGFRB | PLATELET-DERIVED GROWTH FACTOR RECEPTOR, BETA; PDGFRB | ||
| *173445 | PECM1 | PLATELET-ENDOTHELIAL CELL ADHESION MOLECULE; PECAM1 | ||
| 189800 | PEE1 | PREECLAMPSIA/ECLAMPSIA 1 | ||
| *171190 | PENT, PNMT | PHENYLETHANOLAMINE N-METHYLTRANSFERASE | ||
| #264350 | PHA1 | PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE | ||
| *145260 | PHA2 | PSEUDOHYPOALDOSTERONISM, TYPE II | ||
| *601844 | PHA2B | PSEUDOHYPOALDOSTERONISM TYPE II, LOCUS B | ||
| *107400 | PI | PROTEASE INHIBITOR 1 | ||
| *147935 | PI4 | PROTEASE INHIBITOR 4; PI4 | ||
| *601313 | PKD1 | POLYCYSTIC KIDNEY DISEASE 1 | ||
| *173910 | PKD2 | POLYCYSTIC KIDNEY DISEASE 2 | ||
| 600666 | PKD3 | POLYCYSTIC KIDNEY DISEASE 3, AUTOSOMAL DOMINANT | ||
| *263200 | PKHD1 | POLYCYSTIC KIDNEY AND HEPATIC DISEASE-1 | ||
| *602316 | PLA2 | PHOSPHOLIPASE A2 (PLA2) | ||
| *172410 | PLA2G1B | PHOSPHOLIPASE A2, GROUP IB | ||
| *603602 | PLA2G4A | PHOSPHOLIPASE A2, GROUP IVA; PLA2G4A | ||
| *601192 | PLA2G5 | PHOSPHOLIPASE A2, GROUP V; PLA2G5 | ||
| *178600 | PPH1 | PULMONARY HYPERTENSION, PRIMARY | ||
| *176785 | PRCP | PROLYLCARBOXYPEPTIDASE; PRCP PCP ANGIOTENSINASE C |
||
| PRKG1 | ||||
| PRKG2 | ||||
| *176802 | PTGER1 | PROSTAGLANDIN E RECEPTOR 1, EP1 SUBTYPE; PTGER1 | ||
| *176804 | PTGER2 | PROSTAGLANDIN E RECEPTOR 2, EP2 SUBTYPE; PTGER2 | ||
| PTGFBR | PTGF beta RECEPTOR | |||
| *600563 | PTGFR | PROSTAGLANDIN F RECEPTOR; PTGFR PROSTAGLANDIN RECEPTOR F(2-ALPHA) |
||
| *600262 | PTGS2 | PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 2; PTGS2 | ||
| *168470 | PTHLH | PARATHYROID HORMONE-LIKE HORMONE; PTHLH | ||
| *168468 | PTHR | PARATHYROID HORMONE RECEPTOR 1; PTHR1 | ||
| *601469 | PTHR2 | PARATHYROID HORMONE RECEPTOR 2; PTHR2 | ||
| *176785 | PRCP | PROLYLCARBOXYPEPTIDASE | ||
| *177850 | PXE | PSEUDOXANTHOMA ELASTICUM, AUTOSOMAL DOMINANT | ||
| *164760 | RAF1 | V-RAF-1 MURINE LEUKEMIA VIRAL ONCOGENE HOMOLOG 1; RAF1 | ||
| 180260 | RBP1 | RETINOL-BINDING PROTEIN 1; | ||
| *179820 | REN | RENIN | ||
| *312420 | RENBP | RENIN-BINDING PROTEIN; RENBP |
||
| *268400 | RTS | ROTHMUND-THOMSON SYNDROME | ||
| *145505 | SA, SAH | HYPERTENSION ASSOCIATED GENE | ||
| *603967 | SCN4A | SODIUM CHANNEL, VOLTAGE-GATED, TYPE IV, ALPHA SUBUNIT; SCN4A | ||
| *182392 | SCN6A | SODIUM CHANNEL, NEURONAL TYPE VI, ALPHA SUBUNIT; SCN6A | ||
| *600228 | SCNN1A, SCNN1, SCNEA | SODIUM CHANNEL,
NONVOLTAGE-GATED 1, ALPHA SUBUNIT; SCNN1A, SCNN1 SODIUM CHANNEL, EPITHELIAL, ALPHA SUBUNIT; SCNEA |
||
| Epithelial Sodium Channel ENaC | ||||
| *600228 | SODIUM CHANNEL, NONVOLTAGE-GATED 1, ALPHA SUBUNIT; SCNN1A | |||
| *600760 | SCNN1B, SCNEB | SODIUM CHANNEL,
NONVOLTAGE-GATED 1 BETA SUBUNIT; SCNN1B SODIUM CHANNEL, EPITHELIAL, BETA SUBUNIT; SCNEB |
||
| *601328 | SCNN1D | SODIUM CHANNEL, NONVOLTAGE-GATED 1, DELTA | ||
| *600761 | SCNN1G | SODIUM CHANNEL, NONVOLTAGE-GATED 1 GAMMA | ||